Welcome to Dividend.com. Please help us personalize your experience.

Select the one that best describes you

Your personalized experience is almost ready.

Join other Individual Investors receiving FREE personalized market updates and research. Join other Institutional Investors receiving FREE personalized market updates and research. Join other Financial Advisors receiving FREE personalized market updates and research.

Thank you!

Check your email and confirm your subscription to complete your personalized experience.

Thank you for your submission, we hope you enjoy your experience


Pricing
Go Premium Now
Login
Best Dividend Stocks
Ex-Dividend Dates
High Yield Stocks
Strategies
Tools
Articles
Premium
Advisors
Guaranteed Income

abbvie logo in blue

News

Analyst Moves: Abbvie, Cardinal Health, Avon Products, More (ABBV, CAH, AVP)

Mike Deane Feb 02, 2015


Before Monday’s opening bell, a number of big name dividend stocks were the subject of analyst moves. Below, we highlight the important analyst commentary for investors.


Morgan Stanley Downgrades Cardinal Health

Cardinal Health (CAH ) was downgraded to “Equal-weight” at Morgan Stanley, due to a valuation call and price target of $86. Morgan Stanley’s $86 price target on CAH, suggests a 3% upside to the stock’s current price. CAH has dividend yield of 1.65%.

Keybanc Downgrades Crane

Crane Co. (CR ) was downgraded to “Hold” from “Buy” at Keybanc, based on a valuation call. Crane has a dividend yield of 2.17%.

Jefferies Downgrades Nabors Industries

Nabors Industries (NBR ) was downgraded to “Underperform” from “Hold” at Jefferies, due to lower oil prices. Jefferies has a price target of $8 on NBR, suggesting a 30% downside to the stock’s current price. NBR has a yield of 1.39%.

Telsey Downgrades Staples

Staples (SPLS ) was downgraded to “Underperform” from “Market Perform” at Telsey Advisory, based on a valuation call, as the analyst firm believes Staples’ stock price already factors in activist action. Telsey has an $18 price target on Staples, suggesting the stock will rise 6% from its current price. SPLS has a yield of 2.82%,

Deutsche Bank Downgrades Wyndham Worldwide

Wyndham Worldwide (WYN ) was downgraded to “Sell” from “Hold” at Deutsche Bank, due to WYN’s multiple negative catalysts. DB has a price target of $69 on WYN, suggesting an 18% downside to the stock’s current price. WYN has a yield of 1.67%.

Morgan Stanley Cuts Numbers on AbbVie

AbbVie Inc. (ABBV ) had its price target and estimates cut as Morgan Stanley, as the company is seeing lower sales for its hepatitis-C vaccine. MS now has a price target of $65 on ABBV, suggesting an 8% upside. ABBV has a yield of 3.25%.

Credit Suisse Lowers Numbers on Avon Products

Avon Products (AVP ) had its price target and estimates lowered at Credit Suisse, due to the company’s lower sales expectations. Credit Suisse now has a $9 price target on AVP, suggesting a 16% upside to the stock’s price. AVP has a yield of 3.1%.

Popular Articles